Cargando…

Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds

Objective: Burn-injured patients are highly susceptible to infectious complications, which are often associated with increased morbidity and mortality. Rates of antibiotic resistance have increased, and resistant species such as methicillin-resistant Staphylococcus aureus provide additional challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosanov, Lauren B., Jo, Daniel Y., Randad, Pranay R., Moffatt, Lauren T., Carney, Bonnie C., Ortiz, Rachel T., Shupp, Jeffrey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Science Company, LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600145/
https://www.ncbi.nlm.nih.gov/pubmed/28943993
_version_ 1783264197512003584
author Nosanov, Lauren B.
Jo, Daniel Y.
Randad, Pranay R.
Moffatt, Lauren T.
Carney, Bonnie C.
Ortiz, Rachel T.
Shupp, Jeffrey W.
author_facet Nosanov, Lauren B.
Jo, Daniel Y.
Randad, Pranay R.
Moffatt, Lauren T.
Carney, Bonnie C.
Ortiz, Rachel T.
Shupp, Jeffrey W.
author_sort Nosanov, Lauren B.
collection PubMed
description Objective: Burn-injured patients are highly susceptible to infectious complications, which are often associated with increased morbidity and mortality. Rates of antibiotic resistance have increased, and resistant species such as methicillin-resistant Staphylococcus aureus provide additional challenges in the form of virulence factors. Proteins can disrupt local healing, leading to systemic immune disruption. To optimize outcomes, treatments that reduce pathogenicity must be identified. This study aims to compare a glycylcycline antibiotic—tigecycline—with clindamycin for effectiveness in treating superantigenic methicillin-resistant Staphylococcus aureus in burn wounds. Methods: Sprague-Dawley rats received paired 2 × 2-cm burn wounds, which were subsequently inoculated with known virulence factor–producing methicillin-resistant Staphylococcus aureus or media alone on postinjury day 1. Infected animals received twice-daily tigecycline (high or low dose), twice-daily clindamycin (high or low dose), or saline alone (positive controls). Daily sampling and imaging assessments were performed. Results: Bacterial counts and toxin levels were reduced significantly in antibiotic-treated groups relative to positive controls (P < .001). Results from day 7 showed measurable toxin levels in clindamycin-treated, but not tigecycline-treated, wounds. Imaging analysis revealed a return of wound perfusion in tigecycline-treated animals similar to the sham animals. Transcript analysis using polymerase chain reaction and polymerase chain reaction arrays demonstrated downregulation of gene expression in antibiotic-treated animals as compared with positive controls. Conclusions: Overall, this study supports the use of tigecycline in the treatment of methicillin-resistant Staphylococcus aureus–infected burn wounds. While both protein synthesis inhibitors are effective, tigecycline appears to be superior in controlling toxin levels, enabling better wound healing.
format Online
Article
Text
id pubmed-5600145
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Open Science Company, LLC
record_format MEDLINE/PubMed
spelling pubmed-56001452017-09-22 Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds Nosanov, Lauren B. Jo, Daniel Y. Randad, Pranay R. Moffatt, Lauren T. Carney, Bonnie C. Ortiz, Rachel T. Shupp, Jeffrey W. Eplasty Journal Article Objective: Burn-injured patients are highly susceptible to infectious complications, which are often associated with increased morbidity and mortality. Rates of antibiotic resistance have increased, and resistant species such as methicillin-resistant Staphylococcus aureus provide additional challenges in the form of virulence factors. Proteins can disrupt local healing, leading to systemic immune disruption. To optimize outcomes, treatments that reduce pathogenicity must be identified. This study aims to compare a glycylcycline antibiotic—tigecycline—with clindamycin for effectiveness in treating superantigenic methicillin-resistant Staphylococcus aureus in burn wounds. Methods: Sprague-Dawley rats received paired 2 × 2-cm burn wounds, which were subsequently inoculated with known virulence factor–producing methicillin-resistant Staphylococcus aureus or media alone on postinjury day 1. Infected animals received twice-daily tigecycline (high or low dose), twice-daily clindamycin (high or low dose), or saline alone (positive controls). Daily sampling and imaging assessments were performed. Results: Bacterial counts and toxin levels were reduced significantly in antibiotic-treated groups relative to positive controls (P < .001). Results from day 7 showed measurable toxin levels in clindamycin-treated, but not tigecycline-treated, wounds. Imaging analysis revealed a return of wound perfusion in tigecycline-treated animals similar to the sham animals. Transcript analysis using polymerase chain reaction and polymerase chain reaction arrays demonstrated downregulation of gene expression in antibiotic-treated animals as compared with positive controls. Conclusions: Overall, this study supports the use of tigecycline in the treatment of methicillin-resistant Staphylococcus aureus–infected burn wounds. While both protein synthesis inhibitors are effective, tigecycline appears to be superior in controlling toxin levels, enabling better wound healing. Open Science Company, LLC 2017-09-07 /pmc/articles/PMC5600145/ /pubmed/28943993 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/2.0/ This is an open-access article whereby the authors retain copyright of the work. The article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Journal Article
Nosanov, Lauren B.
Jo, Daniel Y.
Randad, Pranay R.
Moffatt, Lauren T.
Carney, Bonnie C.
Ortiz, Rachel T.
Shupp, Jeffrey W.
Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title_full Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title_fullStr Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title_full_unstemmed Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title_short Effectiveness of a Glycylcycline Antibiotic for Reducing the Pathogenicity of Superantigen-Producing Methicillin-Resistant Staphylococcus aureus in Burn Wounds
title_sort effectiveness of a glycylcycline antibiotic for reducing the pathogenicity of superantigen-producing methicillin-resistant staphylococcus aureus in burn wounds
topic Journal Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600145/
https://www.ncbi.nlm.nih.gov/pubmed/28943993
work_keys_str_mv AT nosanovlaurenb effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT jodaniely effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT randadpranayr effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT moffattlaurent effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT carneybonniec effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT ortizrachelt effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds
AT shuppjeffreyw effectivenessofaglycylcyclineantibioticforreducingthepathogenicityofsuperantigenproducingmethicillinresistantstaphylococcusaureusinburnwounds